Laser Induced Choroidal Neovascularization (CNV) as a Model of Age-related Macular Degeneration (AMD) in the Minipig

Introduction

Choroidal Neovascularization (CNV) is a known cause of Age-Related Macular Degeneration (AMD). Lucentis® (ranibuzumab) is a marketed treatment for AMD, and is hypothesized to function by binding to vascular endothelial growth factors (VEGF) and preventing aberrant vascular growth. Ocular similarities between humans and the minipig make it a useful model for ocular therapies, and this study aimed to validate the minipig model of laser induced CNV.

Authors

Stricker-Krongrad, A., Leigh, H., Harvey, R.M., Jones, M.R., Tellez, A., Stanley, J., Wicks, J., Bouchard G.F.

Download this Scientific Poster

Upcoming Webinar

Join Scott E. Boley on June 10th for this live webinar.

SAVE YOUR SEAT

You have Successfully Subscribed!